Lashen, A.; Algethami, M.; Alqahtani, S.; Shoqafi, A.; Sheha, A.; Jeyapalan, J.N.; Mongan, N.P.; Rakha, E.A.; Madhusudan, S.
The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers. Int. J. Mol. Sci. 2024, 25, 4060.
https://doi.org/10.3390/ijms25074060
AMA Style
Lashen A, Algethami M, Alqahtani S, Shoqafi A, Sheha A, Jeyapalan JN, Mongan NP, Rakha EA, Madhusudan S.
The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers. International Journal of Molecular Sciences. 2024; 25(7):4060.
https://doi.org/10.3390/ijms25074060
Chicago/Turabian Style
Lashen, Ayat, Mashael Algethami, Shatha Alqahtani, Ahmed Shoqafi, Amera Sheha, Jennie N. Jeyapalan, Nigel P. Mongan, Emad A. Rakha, and Srinivasan Madhusudan.
2024. "The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers" International Journal of Molecular Sciences 25, no. 7: 4060.
https://doi.org/10.3390/ijms25074060
APA Style
Lashen, A., Algethami, M., Alqahtani, S., Shoqafi, A., Sheha, A., Jeyapalan, J. N., Mongan, N. P., Rakha, E. A., & Madhusudan, S.
(2024). The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers. International Journal of Molecular Sciences, 25(7), 4060.
https://doi.org/10.3390/ijms25074060
